GLOBAL DNA SEQUENCING MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL DNA SEQUENCING MARKET FORECAST 2019-2027

GLOBAL DNA SEQUENCING MARKET FORECAST 2019-2027

The global DNA sequencing market is anticipated to grow at a CAGR of 17.46% between 2019 and 2027. DNA sequencing is the process to determine the exact order of the four chemical buildings blocks, known as the bases that are responsible for the formation of the DNA molecule. The following factors primarily drive the DNA sequencing market: Growing breeders requirement for the animals & plants reproduction

GLOBAL DNA SEQUENCING MARKET FORECAST 2019-2027

DNA Sequencing Market by End-user (Research Centers and Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, & Other) by Technology (Illumina Synthesis, Ion Semiconductor Sequencing, by Sequencing by Ligation, by Pyrosequencing, Single-molecule Real-time Sequencing & Other) by Application (Diagnostics, Drug Discovery, Biomarker Discovery,  Personalized Medicine, Agriculture & Animal Research & Other) by Geography

Request free sample

The global DNA sequencing market is anticipated to grow at a CAGR of 17.46% between 2019 and 2027. DNA sequencing is the process to determine the exact order of the four chemical buildings blocks, known as the bases that are responsible for the formation of the DNA molecule. The following factors primarily drive the DNA sequencing market:

  • Growing breeders requirement for the animals & plants reproduction
  • Developing technology and applied markets
  • Increasing research and development in DNA sequencing market
  • Increasing prevalence of cancer cases
  • Entry of new market players
  • Increasing conferences and workshops related to DNA sequencing market
  • Continuing decline in sequencing costs
  • Growth in liquid biopsy applications
  • Increasing personalized therapies
  • Surge in genome mapping programs

The important drivers that are triggering an accumulative growth in the global DNA sequencing market are increasing research and development in the DNA sequencing market and the rising prevalence of cancer cases. The rapid research and development are greatly accelerating the market for DNA sequencing. The principal DNA sequences were attained in the early 1970s by educational researchers who expended laborious approaches grounded on two-dimensional chromatography. The growing occurrences of cancer among the population is another chief driver enhancing the worldwide DNA sequencing market. A genomic era of cancer studies is proceeding forward at a rapid pace, propelled by the advent of next-generation sequencing techniques that offers sharp resolution and sensitivity.

The DNA sequencing market has extensive applications for various purposes and employs several technologies. When sequencing is carried out by synthesis technology, either DNA polymerase or ligase enzymes are used to extend the DNA strands in parallel to the template DNA. The ion semiconductor sequencing is based on the hydrogen ion detection that are released during the polymerization process of DNA. Sequencing by ligation (SBL) process for DNA sequencing employs the enzyme DNA ligase to identify the nucleotide present at a given position in a DNA sequence and the resulting occurrence is read out through a software. Pyrosequencing is described as a novel DNA sequencing technology and is represented as the first alternative to the conventional Sanger sequencing method for de novo DNA sequencing. Single-molecule real-time sequencing technology is being regarded as a third generation technology. Nanopore sequencing is a fourth generation sequencing method, which is used for sequencing genetic materials. Advancements in DNA sequencing technology have permitted a comprehensive investigation of the genetics of human beings and human diseases. The DNA sequencing technology is widely used for drug development due to its success in the much proclaimed human genome project. Biomarker refers to a distinguishing indicator that is objectively evaluated and measured as a sign of disease processes, normal biological processes or biological responses to a therapeutic intervention. Personalized medicine also referred to as individualized medicine, is an emerging field of medicine that uses diagnostic tools to identify specific biological markers. DNA sequencing also plays a crucial role in forensics research.

Standardization, accuracy and ethical concerns in diagnostic testing and harm to the skilled professionals while chemical handling can severely hinder the growth of the DNA sequencing market. For medical molecular diagnostic testing, the accuracy of deoxyribonucleic acid (DNA) sequence analysis depends on at least three mechanisms. The main reason for the shortage of skilled professionals is the lack of awareness among people regarding DNA sequencing techniques, and the lack of trained professionals as this technology is still in its initial phase of development.

The global DNA sequencing market segments include end users, technologies, applications and products.

End users are segmented into:

  • Research centers and academic & government institutes
  • Biotechnology companies
  • Pharmaceutical
  • Hospitals & Clinics
  • Other end-users

Technologies are segmented into:

  • Sequencing by synthesis
  • Nanopore sequencing
  • Sequencing by ligation (SBL)
  • Ion semiconductor sequencing
  • Pyrosequencing
  • Chain termination sequencing
  • Single-molecule real-time sequencing (SMRT)
  • Other technologies

Applications are segmented into:

  • Diagnostics
  • Drug discovery
  • Biomarker discovery
  • Personalized medicine
  • Agriculture & animal research
  • Reproductive health
  • Forensics
  • Other applications

Products are segmented into:

  • Sequencing services
  • Sequencing instruments and consumables
  • Sequencing instruments and consumables by product type
    • Consumables
    • Instruments
  • Sequencing instruments and consumables by platform
    • NGS
    • Sanger
  • Bioinformatics
  • Sample prep kits and reagents

This report covered the present market conditions and the growth prospects of the global DNA sequencings market for 2019-2027. The report considered the revenue generated through the sales of DNA sequencing techniques employed with respect to types as well as applications to calculate the market size by considering 2018 as the base year.

Geographically, the global DNA sequencings market has been segmented on the basis of four major regions, which include:

  • North America – The United States & Canada
  • Asia-Pacific –Japan, India, China, Australia, Korea & Rest of APAC
  • Europe – The United Kingdom, Spain, Germany, France, Italy & Rest of Europe
  • Rest of World- the Middle East and North Africa, Latin America & Rest of Africa

The DNA sequencing market in North America is expected to hold the largest share by 2027 possibly because of growing geriatric population and the prevalence of various chronic disorders. In North America, the prevalence of various cancer such as prostate cancer, breast cancer, bronchus cancer, bladder cancer, rectum and colon cancer, melanoma of the skin, Non-Hodgkin lymphoma, renal pelvis cancer, thyroid cancer, endometrial cancer, pancreatic cancer and other form of cancer are growing rapidly due to which the demand for DNA sequencing is continuously snowballing.

On the other hand, the Asia-Pacific market is anticipated to the fastest-growing region for the smart DNA Sequencing market. India, China and Japan are the emerging nations which are contributing to the growth of Asia-Pacific DNA sequencing market. In India and China, there has been a growing number of elderly population and changing lifestyle which are becoming the major factors due to which various chronic disorder can be caused such as cancer, diabetes and others.

The DNA sequencing market is segmented based on the end users which is sub-divided into research centers and clinics & hospitals, government institutes & academic, biotechnology companies, pharmaceutical, and other end-users. Also, the segmentation on the basis of products is further sub-divided into sequencing services; sequencing instruments & consumables; bioinformatics and sample prep kits and reagents. The research centers are continuously adapting DNA sequencing technology to identify the relationship between various diseases and to develop a specific treatment for it. In hospitals and clinics, DNA sequencing technology is being used to develop the treatments and vaccines specific to certain diseases like genetic diseases. In the healthcare sector, one of the most innovative and fast-growing fields is genomics, which comprises the sequencing and analysis of the human genome (complete set of DNA). The growth in sequencing services benefits from several trends in the industry. Sequencing economies of scale are being achieved by many service providers who have more than one high-throughput NGS instrument. DNA sequencing instruments consist of Sanger, NGS and emerging (e.g., single molecule or nanopore systems) formats. DNA sequencing consumables consist of products consumed in the sequencing reaction itself.

The major market players in the global DNA sequencing market are:

  • Adaptive Biotechnologies, Inc.
  • Agilent Technologies, Inc.
  • BGI
  • Illumina
  • Thermo Fisher Scientific, Inc.

Company profiles covers analysis of important players. Founded in 2010 as a spin-off of the Fred Hutchinson Cancer Research Center in Seattle, Adaptive Biotechnologies provides immune repertoire-sequencing and data analysis services. Adaptive Biotechnologies is a leader in NGS for sequencing of T- and B-cell receptors. The company also is building a database of immune biomarkers, which can identify targets for use in immunotherapies. The acquisition of Life Technologies enhanced Thermo Fisher’s ability to market itself to life science research customer base as a one-stop shop for both instruments and consumables. Life Technologies markets a wide range of consumables, further enhancing the Thermo Fisher customer base.

Key Findings of the Global DNA Sequencing market are:

  • Rising use of personalized medicines
  • Growth in sequencing services
  • Research centers and academic & government institutes hold the largest market share in terms of the end user
  • Sequencing by synthesis is the widely used DNA sequencing technology
  • Biomarker is the most popular DNA sequencing application
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • RISING USE OF PERSONALIZED MEDICINES
      • GROWTH IN SEQUENCING SERVICES
      • RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES HOLDS THE LARGEST MARKET SHARE IN TERMS OF END USER
      • SEQUENCING BY SYNTHESIS IS THE WIDELY USED DNA SEQUENCING TECHNOLOGY
      • BIOMARKER IS THE MOST POPULAR DNA SEQUENCING APPLICATION
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • GROWING BREEDERS REQUIREMENT FOR THE ANIMALS & PLANTS REPRODUCTION
      • DEVELOPING TECHNOLOGY AND APPLIED MARKETS
      • INCREASING RESEARCH AND DEVELOPMENT IN DNA SEQUENCING MARKET
      • INCREASING PREVALENCE OF CANCER CASES
      • ENTRY OF NEW MARKET PLAYERS
      • INCREASING CONFERENCES AND WORKSHOPS RELATED TO DNA SEQUENCING MARKET
      • CONTINUING DECLINE IN SEQUENCING COSTS
      • GROWTH IN LIQUID BIOPSY APPLICATIONS
      • INCREASING PERSONALIZED THERAPIES
      • SURGE IN GENOME MAPPING PROGRAMS
    • MARKET RESTRAINTS
      • ACCURACY AND STANDARDIZATION CONCERNS IN DIAGNOSTIC TESTING
      • LACK OF SKILLED PROFESSIONALS
    • MARKET OPPORTUNITIES
      • GROWTH IN DEVELOPING COUNTRIES
      • INFLUENCE OF PERSONALIZED MEDICINE & BIOMARKER DISCOVERY
      • INCREASING GROWTH OF THE Y CHROMOSOME TESTING MARKET
      • ADVANCEMENT IN NGS (NEXT GENERATION SEQUENCING)
    • MARKET CHALLENGES
      • FRONT AND BACK-END CHALLENGES
      • LIMITATIONS IN BIOINFORMATICS
      • SOCIAL AND ETHICAL ISSUES
  1. MARKET BY END USER
    • RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
    • HOSPITALS & CLINICS
    • PHARMACEUTICAL
    • BIOTECHNOLOGY COMPANIES
    • OTHER END-USERS
  2. MARKET BY TECHNOLOGY
    • SEQUENCING BY SYNTHESIS
    • ION SEMICONDUCTOR SEQUENCING
    • SEQUENCING BY LIGATION (SBL)
    • PYROSEQUENCING
    • SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
    • CHAIN TERMINATION SEQUENCING
    • NANOPORE SEQUENCING
    • OTHER TECHNOLOGIES
  3. MARKET BY APPLICATION
    • DIAGNOSTICS
    • DRUG DISCOVERY
    • BIOMARKER DISCOVERY
    • PERSONALIZED MEDICINE
    • AGRICULTURE & ANIMAL RESEARCH
    • REPRODUCTIVE HEALTH
    • FORENSICS
    • OTHER APPLICATIONS
  4. MARKET BY PRODUCTS
    • SEQUENCING SERVICES
    • SEQUENCING INSTRUMENTS AND CONSUMABLES
      • SEQUENCING INSTRUMENTS AND CONSUMABLES BY PRODUCT TYPE
        • CONSUMABLES
        • INSTRUMENTS
      • SEQUENCING INSTRUMENTS AND CONSUMABLES BY PLATFORM
        • NGS
        • SANGER
      • BIOINFORMATICS
      • SAMPLE PREP KITS AND REAGENTS
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • STRATEGIC CONCLUSIONS
    • DNA SEQUENCING TIMELINE
    • OPPORTUNITY MATRIX
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES (US)
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM (UK)
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • KOREA
      • AUSTRALIA
      • REST OF APAC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILES
      • ABBOTT LABORATORIES.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ADAPTIVE BIOTECHNOLOGIES, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • AGILENT TECHNOLOGIES, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • APPISTRY, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • ASURAGEN, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • BGI
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • CELL MICROSYSTEMS, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
      • HOFFMANN-LA ROCHE LTD.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC INITIATIVES
      • ILLUMINA
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • PACIFIC BIOSCIENCES
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
      • ROCHE DIAGNOSTICS
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • SPIRAL GENETICS, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • THERMO FISHER SCIENTIFIC, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • UBIQUITY GENOMICS, INC.
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • WAFERGEN BIO-SYSTEMS, INC. (MERGED WITH TAKARA BIO)
        • COMPANY OVERVIEW
        • SCOT ANALYSIS
        • PRODUCT PORTFOLIO
      • ZS GENETICS, INC.
        • COMPANY OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES

LIST OF TABLES

TABLE 1       GLOBAL DNA SEQUENCING MARKET BY GEOGRAPHY 2019-2027 ($ MILLIONS)

TABLE 2       ESTIMATED NEW CASES AND DEATHS DUE TO CANCER 2018

TABLE 3       WORKSHOPS AND CONFERENCES RELATED TO DNA OR NEXT GENERATION SEQUENCING

TABLE 4       GLOBAL DNA SEQUENCING MARKET BY END USER 2019-2027 ($ MILLION)

TABLE 5       GLOBAL RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 6       GLOBAL HOSPITALS & CLINICS MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 7       GLOBAL PHARMACEUTICAL MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 8       GLOBAL BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 9       GLOBAL OTHER END-USER BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 10     GLOBAL DNA SEQUENCING MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)

TABLE 11     SBS PARAMETERS AND DESCRIPTION

TABLE 12     GLOBAL SEQUENCING BY SYNTHESIS MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 13     ION SEMICONDUCTOR SEQUENCING PARAMETERS (ION TORRENT SEQUENCING)

TABLE 14     GLOBAL ION SEMICONDUCTOR SEQUENCING BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 15     SBL (SEQUENCING BY LITIGATION) PARAMETERS (SOLID SEQUENCING)

TABLE 16     GLOBAL SEQUENCING BY LIGATION (SBL) BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 17     ADVANTAGES AND DISADVANTAGES OF PYROSEQUENCING

TABLE 18     GLOBAL PYROSEQUENCING MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 19     SINGLE-MOLECULE REAL-TIME SEQUENCING PARAMETERS (PACIFIC BIOSCIENCES)

TABLE 20     GLOBAL SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 21     GLOBAL CHAIN TERMINATION SEQUENCING MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 22     GLOBAL NANOPORE SEQUENCING MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 23     GLOBAL OTHER TECHNOLOGIES MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 24     GLOBAL DNA SEQUENCING MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 25     FDA-APPROVED DRUGS ALONG WITH A COMPANION DIAGNOSTIC

TABLE 26     GLOBAL DIAGNOSTICS MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 27     GLOBAL DRUG DISCOVERY MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 28     GLOBAL BIOMARKER DISCOVERY MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 29     GLOBAL PERSONALIZED MEDICINE MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 30     GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 31     GLOBAL REPRODUCTIVE HEALTH MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 32     GLOBAL FORENSICS MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 33     GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 34     GLOBAL DNA SEQUENCING MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 35     GLOBAL SEQUENCING INSTRUMENTS AND CONSUMABLES BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 36     GLOBAL SEQUENCING INSTRUMENTS AND CONSUMABLES BY PLATFORMS 2019-2027 ($ MILLION)

TABLE 37     GLOBAL DNA SEQUENCING MARKET BY GEOGRAPHY 2019-2027 ($ MILLION)

TABLE 38     NORTH AMERICA DNA SEQUENCING MARKET BY COUNTRY 2019-2027($ MILLION)

TABLE 39     STATISTICS OF CANCER CASES IN THE U.S.

TABLE 40     EUROPE DNA SEQUENCING MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 41     ASIA PACIFIC DNA SEQUENCING MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 42     REST OF WORLD DNA SEQUENCING MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 43     DIABETES IN BRAZIL

 

LIST OF FIGURES

FIGURE 1     GLOBAL DNA SEQUENCING MARKET 2019-2027 ($ MILLIONS)

FIGURE 2     LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING

FIGURE 3     GLOBAL DNA SEQUENCING MARKET BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 2019-2027 ($ MILLION)

FIGURE 4     GLOBAL DNA SEQUENCING MARKET BY HOSPITALS & CLINICS 2019-2027 ($ MILLION)

FIGURE 5     GLOBAL DNA SEQUENCING MARKET BY PHARMACEUTICAL 2019-2027 ($ MILLION)

FIGURE 6     GLOBAL DNA SEQUENCING MARKET BY BIOTECHNOLOGY COMPANIES 2019-2027 ($ MILLION)

FIGURE 7     BIOTECHNOLOGICAL TOOLS USED FOR CROP PROTECTION

FIGURE 8     GLOBAL DNA SEQUENCING MARKET BY OTHER END-USERS 2019-2027 ($ MILLION)

FIGURE 9     GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY SYNTHESIS 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL DNA SEQUENCING MARKET BY ION SEMICONDUCTOR SEQUENCING 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL DNA SEQUENCING MARKET BY SEQUENCING BY LIGATION (SBL) 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL DNA SEQUENCING MARKET BY PYROSEQUENCING 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL DNA SEQUENCING MARKET BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL DNA SEQUENCING MARKET BY CHAIN TERMINATION SEQUENCING 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL DNA SEQUENCING MARKET BY NANOPORE SEQUENCING 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL DNA SEQUENCING MARKET BY OTHER TECHNOLOGIES 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL DNA SEQUENCING MARKET BY DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL DNA SEQUENCING MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL DNA SEQUENCING MARKET BY BIOMARKER DISCOVERY 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL DNA SEQUENCING MARKET BY PERSONALIZED MEDICINE 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL DNA SEQUENCING MARKET BY AGRICULTURE & ANIMAL RESEARCH 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL DNA SEQUENCING MARKET BY REPRODUCTIVE HEALTH 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL DNA SEQUENCING MARKET BY FORENSICS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL DNA SEQUENCING MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL DNA SEQUENCING MARKET BY SEQUENCING SERVICES 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL DNA SEQUENCING MARKET BY SEQUENCING INSTRUMENTS AND CONSUMABLES 2019-2027 ($ MILLION)

FIGURE 27   GLOBAL SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET BY CONSUMABLES 2019-2027 ($ MILLION)

FIGURE 28   GLOBAL SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)

FIGURE 29   GLOBAL SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET BY NGS 2019-2027 ($ MILLION)

FIGURE 30   GLOBAL SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET BY SANGER 2019-2027 ($ MILLION)

FIGURE 31   GLOBAL DNA SEQUENCING MARKET BY BIOINFORMATICS 2019-2027 ($ MILLION)

FIGURE 32   GLOBAL DNA SEQUENCING MARKET BY SAMPLE PREP KITS AND REAGENTS 2019-2027 ($ MILLION)

FIGURE 33   NUMBER OF CANCER CASES AND DEATHS IN U.S. FOR 2016

FIGURE 34   PREVALENCE OF DIABETES IN CANADA IN 2015 & 2025 (MILLION)

FIGURE 35   THE UNITED STATES DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 36   CANADA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 37   THE UNITED KINGDOM DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 38   FRANCE DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 39   GERMANY DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 40   SPAIN DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 41   ITALY DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 42   REST OF EUROPE DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 43   INDIA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 44   CHINA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 45   JAPAN DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 46   KOREA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 47   AUSTRALIA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 48   ROPAC DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 49   LATIN AMERICA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 50   MEA DNA SEQUENCING MARKET 2019-2027 ($ MILLION)

FIGURE 51   GLOBAL DNA SEQUENCING MARKET SHARE ANALYSIS 2017 (%)

  1. MARKET BY END USER
    • RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
    • HOSPITALS & CLINICS
    • PHARMACEUTICAL
    • BIOTECHNOLOGY COMPANIES
    • OTHER END-USERS
  2. MARKET BY TECHNOLOGY
    • SEQUENCING BY SYNTHESIS
    • ION SEMICONDUCTOR SEQUENCING
    • SEQUENCING BY LIGATION (SBL)
    • PYROSEQUENCING
    • SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
    • CHAIN TERMINATION SEQUENCING
    • NANOPORE SEQUENCING
    • OTHER TECHNOLOGIES
  3. MARKET BY APPLICATION
    • DIAGNOSTICS
    • DRUG DISCOVERY
    • BIOMARKER DISCOVERY
    • PERSONALIZED MEDICINE
    • AGRICULTURE & ANIMAL RESEARCH
    • REPRODUCTIVE HEALTH
    • FORENSICS
    • OTHER APPLICATIONS
  4. MARKET BY PRODUCTS
    • SEQUENCING SERVICES
    • SEQUENCING INSTRUMENTS AND CONSUMABLES
      • SEQUENCING INSTRUMENTS AND CONSUMABLES BY PRODUCT TYPE
        • CONSUMABLES
        • INSTRUMENTS
      • SEQUENCING INSTRUMENTS AND CONSUMABLES BY PLATFORM
        • NGS
        • SANGER
      • BIOINFORMATICS
      • SAMPLE PREP KITS AND REAGENTS
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES (US)
      • CANADA
    • EUROPE
      • THE UNITED KINGDOM (UK)
      • FRANCE
      • GERMANY
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • INDIA
      • CHINA
      • JAPAN
      • KOREA
      • AUSTRALIA
      • REST OF APAC
    • REST OF THE WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now